Business
Herbalife Delivers Fourth Quarter and Full-Year Net Sales Growth, Net Sales and Adjusted EBITDA1 Exceed Guidance
LOS ANGELES, February 18, 2026--Herbalife Ltd. (NYSE: HLF) today reported financial results for the fourth quarter and year ended December 31, 2025:
About this update from Herbalife Ltd.
[{"type":"image","alt":"Q4 2025 Earnings Press Release","displaySize":"","headline":null,"caption":"Q4 2025 Earnings Press Release","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":350,"height":480,"url":"https://media.zenfs.com/en/business-wire.com/444c196be494b210714e4f0bdfc922ad"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/TLXs3YrsrzKGS4MzJfo9xA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTg3ODtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/444c196be494b210714e4f0bdfc922ad","width":350,"height":480}},"lazy":false},{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":5001,"height":1383,"url":"https://media.zenfs.com/en/business-wire.com/d9db580b1bf8bd474c927ae38cf22625"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/.uYCpl94UTQgP2wbbA.4Tw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTI2NTtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/d9db580b1bf8bd474c927ae38cf22625","width":960,"height":265},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/AtzkMXOtLpkgkUXN0BxB.Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD02NjQ7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/d9db580b1bf8bd474c927ae38cf22625","width":1200,"height":332}}},{"type":"text","content":"Cristiano Ronaldo Invests $7.5 Million in Herbalife’s Pro2col™ Technology","length":73,"tagName":"p","attribs":{}},{"type":"text","content":"LOS ANGELES, February 18, 2026--(BUSINESS WIRE)--Herbalife Ltd. (NYSE: HLF) today reported financial results for the fourth quarter and year ended December 31, 2025:","length":165,"tagName":"p"},{"type":"text","content":""We exited 2025 with solid momentum, delivering Q4 and full‑year net sales growth and adjusted EBITDA1 above guidance. Cristiano Ronaldo’s investment in Pro2col reflects our shared ambition to scale personalized nutrition and wellness globally—uniting science, data, AI, innovation, and community to improve the health and performance of millions."","length":358,"tagName":"p"},{"type":"text","content":"- Stephan Gratziani, CEO","length":24,"tagName":"p"},{"type":"text","content":"Highlights","length":10,"tagName":"p"},{"type":"text","content":"Fourth Quarter 2025","length":19,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Net sales up 6.3% vs. Q4 ‘24 to $1.3 billion; ...